| The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis A Sangiovanni, MA Manini, M Iavarone, R Romeo, LV Forzenigo, ... Gut 59 (5), 638-644, 2010 | 488 | 2010 |
| Low resistance to adefovir combined with lamivudine: a 3-year study of 145 lamivudine-resistant hepatitis B patients P Lampertico, M Vigano, E Manenti, M Iavarone, E Sablon, M Colombo Gastroenterology 133 (5), 1445-1451, 2007 | 440 | 2007 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology 54 (6), 2055-2063, 2011 | 418 | 2011 |
| High rates of 30-day mortality in patients with cirrhosis and COVID-19 M Iavarone, R D'Ambrosio, A Soria, M Triolo, N Pugliese, P Del Poggio, ... Journal of hepatology 73 (5), 1063-1071, 2020 | 384 | 2020 |
| Adefovir rapidly suppresses hepatitis B in HBeAg‐negative patients developing genotypic resistance to lamivudine P Lampertico, M Viganò, E Manenti, M Iavarone, G Lunghi, M Colombo Hepatology 42 (6), 1414-1419, 2005 | 375 | 2005 |
| The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma L Di Tommaso, A Destro, JY Seok, E Balladore, L Terracciano, ... Journal of hepatology 50 (4), 746-754, 2009 | 337 | 2009 |
| Prognostic gene expression signature for patients with hepatitis C–related early-stage cirrhosis Y Hoshida, A Villanueva, A Sangiovanni, M Sole, C Hur, KL Andersson, ... Gastroenterology 144 (5), 1024-1030, 2013 | 236 | 2013 |
| Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians P Arends, MJ Sonneveld, R Zoutendijk, I Carey, A Brown, M Fasano, ... Gut 64 (8), 1289-1295, 2015 | 226 | 2015 |
| Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial V Mazzaferro, D Citterio, S Bhoori, M Bongini, R Miceli, L De Carlis, ... The Lancet Oncology 21 (7), 947-956, 2020 | 225 | 2020 |
| Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 213 | 2018 |
| Molecular liver cancer prevention in cirrhosis by organ transcriptome analysis and lysophosphatidic acid pathway inhibition S Nakagawa, L Wei, WM Song, T Higashi, S Ghoshal, RS Kim, CB Bian, ... Cancer cell 30 (6), 879-890, 2016 | 184 | 2016 |
| Survival of patients with HCV cirrhosis and sustained virologic response is similar to the general population S Bruno, V Di Marco, M Iavarone, L Roffi, A Crosignani, V Calvaruso, ... Journal of Hepatology 64 (6), 1217-1223, 2016 | 158 | 2016 |
| VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study M Scartozzi, L Faloppi, G Svegliati Baroni, C Loretelli, F Piscaglia, ... International journal of cancer 135 (5), 1247-1256, 2014 | 144 | 2014 |
| Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib M Iavarone, G Cabibbo, M Biolato, C Della Corte, M Maida, M Barbara, ... Hepatology 62 (3), 784-791, 2015 | 135 | 2015 |
| Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound M Galassi, M Iavarone, S Rossi, S Bota, S Vavassori, L Rosa, S Leoni, ... Liver International 33 (5), 771-779, 2013 | 132 | 2013 |
| Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis M Iavarone, F Piscaglia, S Vavassori, M Galassi, A Sangiovanni, ... Journal of Hepatology 58 (6), 1188-1193, 2013 | 129 | 2013 |
| A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection DY Zhang, N Goossens, J Guo, MC Tsai, HI Chou, C Altunkaynak, ... Gut 65 (10), 1754-1764, 2016 | 124 | 2016 |
| Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection M Iavarone, JB Trabut, O Delpuech, F Carnot, M Colombo, D Kremsdorf, ... Journal of hepatology 39 (2), 253-261, 2003 | 124 | 2003 |
| Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma C Cammà, G Cabibbo, S Petta, M Enea, M Iavarone, A Grieco, ... Hepatology 57 (3), 1046-1054, 2013 | 117 | 2013 |
| Assessing tumor angiogenesis: increased circulating VE-cadherin RNA in patients with cancer indicates viability of circulating endothelial cells C Rabascio, E Muratori, P Mancuso, A Calleri, V Raia, T Foutz, S Cinieri, ... Cancer research 64 (12), 4373-4377, 2004 | 109 | 2004 |
